- Hisashi Moriguchi (email@example.com), professor,
- Takamoto Uemura, assistant professor,
- Chifumi Sato, professor
- Laboratory for Systems Biology and Medicine, RCAST, University of Tokyo, 4-6-1, Komaba, Meguro-ku, Tokyo, Japan 153-8904
- Kyorin University, Tokyo
- Tokyo Medical and Dental University, Tokyo
EDITOR—Manuel et al show that guidelines on statin treatment should focus on people with the highest risk of coronary heart disease.1 However, concerns about the optimal choice of statins remain.
A recent meta-analysis (n = 71 108) of randomised controlled trials has shown that the occurrence of myalgia is less common with fluvastatin, pravastatin, and simvastatin than atorvastatin (odds …